Vanda Pharmaceuticals reported $6.57M in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 5.21M 0.51M
Acorda Therapeutics ACOR:US $ 11.32M 0.64M
Akebia Therapeutics AKBA:US $ 44.38M 18.09M
Alnylam Pharmaceuticals ALNY:US $ 30.26M 7.23M
Anika Therapeutics ANIK:US $ 17.33M 4.01M
AstraZeneca AZN:LN 2193M 273M
Bluebird Bio BLUE:US $ 15.3M 13.02M
Bristol Myers Squibb BMY:US $ 2451M 52M
Clovis Oncology CLVS:US $ 9.64M 0.03M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Esperion Therapeutics ESPR:US $ 1.8M 16K
Halozyme Therapeutics HALO:US $ 23.02M 4.8M
Heron Therapeutics HRTX:US $ 14.52M 5.32M
Insmed INSM:US $ 10.84M 993K
Intercept Pharmaceuticals ICPT:US $ 0.62M 0.19M
Johnson & Johnson JNJ:US $ 7567M 531M
Lexicon Pharmaceuticals LXRX:US $ 0M 0M
Ligand Pharmaceuticals LGND:US $ 30.59M 22.44M
Merk MRK:US $ 2684M 771M
Moderna Inc MRNA:US 750M 557M
Novartis NVS:US $ 3754M 79M
Pfizer PFE:US $ 6992M 2820M
Ptc Therapeutics PTCT:US $ 7.36M 1.75M
Puma Biotechnology PBYI:US $ 11.97M 17.59M
Takeda 4502:JP Y 241264M 12182M
Teva Pharmaceutical TEVA:IT 1.99B 76M
Ultragenyx Pharmaceutical RARE:US $ 3.14M 2.05M
Vanda Pharmaceuticals VNDA:US $ 6.57M 0.54M
Veracyte VCYT:US $ 17.47M 5.07M